Transcription profiling in papillary thyroid carcinoma reveals potential diagnostic markers and drug targets by unknown
POSTER PRESENTATION Open Access
Transcription profiling in papillary thyroid
carcinoma reveals potential diagnostic markers
and drug targets
Mateus CB Filho1*, Fabio A Marchi2, Silvia R Rogatto1,3, Luiz P Kowalski1
From São Paulo Advanced School of Comparative Oncology
Águas de São Pedro, Brazil. 30 September - 6 October 2012
Background
Papillary thyroid carcinoma (PTC) is the most frequent
malignant endocrine neoplasia with an increasing preva-
lence in the last decades. We aim to identify transcripts
and pathways associated with PTC tumorigenesis.
Materials and methods
RNA from tumor and adjacent normal samples was evalu-
ated using Sure Print G3 8x60K slides (Agilent Technolo-
gies). Sixty-five tumor (T) and four normal (N) tissues
were labeled with Cy5. A pool composed by nine normal
samples (without the corresponding tumor assayed) was
labeled with Cy3 and used in the co-hybridization. Statisti-
cal analysis was performed using two approaches, a paired
(4N vs 4T) and an independent analysis (9N vs. 61T).
Results
Overlapping paired (paired Significance Analysis of Micro-
array with 3% False Discovery Ratio) and independent ana-
lysis (mean log ratios <-1 or >1 with 99% Confidence
Interval) resulted in a list of 546 deregulated genes.
Networks and functional analysis were generated through
IPA software (Ingenuity® Systems). The major molecular
network identified was related to endocrine system devel-
opment and function and down regulation of tyrosine
metabolism was the main canonical pathway. A prelimin-
ary validation was carried out with RT-qPCR for HMGA2.
A higher expression was confirmed (P<0.001) in an inde-
pendent sample set (11N vs. 47T). HMGA2 expression
had also diagnostic ability, correctly classifying 117/121
samples according to tumor status (sensibility=97%, speci-
ficity=94% and area under the ROC curve=0.989).
Conclusion
This study unveils transcription modulations during PTC
genesis and HMGA2 may be a potential diagnostic mar-
ker. Functional studies are required to confirm HMGA2
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